Actionnariat et activité des initiés pour Neurogene Inc. (NGNE): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $34.67 |
| Capitalisation | $548M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-06 | Cvijic Christine Mikail | S-Sale | 600 | $22K |
| 2026-07-07 | Cvijic Christine Mikail | S-Sale | 4,200 | $152K |
| 2026-07-01 | Cvijic Christine Mikail | S-Sale | 739 | $25K |
| 2026-07-02 | Cvijic Christine Mikail | S-Sale | 2,531 | $88K |
| 2026-07-02 | Cvijic Christine Mikail | S-Sale | 1,530 | $54K |
| 2024-01-16 | Woods Keith | A-Award | 15,400 | $497K |
| 2024-06-14 | Woods Keith | A-Award | 7,700 | $328K |
| 2025-06-12 | Woods Keith | A-Award | 12,050 | $246K |
| 2023-12-18 | Woods Keith | |||
| 2026-05-06 | Cvijic Christine Mikail | S-Sale | 4,800 | $144K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $32.3M | $52.0M | $76.9M | $143.1M | $192.6M | $70.5M | $82.0M | $148.2M | $136.6M | $103.8M |
| Placements à Court Terme | $70.8M | $56.1M | 0 | 0 | 0 | 0 | 0 | $48.9M | $175.8M | $165.2M |
| Créances | 0 | 0 | 0 | 0 | 0 | $790000 | 0 | $600000 | $648000 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | $1.9M | 0 | 0 | 0 | 0 |
| Actifs Courants | $103.5M | $108.8M | $77.2M | $143.6M | $194.5M | $74.0M | $84.7M | $200.3M | $315.9M | $271.8M |
| Immobilisations Corporelles | $849000 | $905000 | $400000 | $2.8M | $13.7M | $27.5M | $24.5M | $21.0M | $18.5M | $15.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | $567000 | $347000 | $128000 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $154.4M | $110.3M | $77.6M | $147.0M | $210.5M | $101.5M | $109.3M | $222.6M | $335.7M | $288.6M |
| Dettes Fournisseurs | 0 | 0 | $702000 | $1.6M | $1.3M | $5.6M | $625000 | $2.6M | $1.3M | $2.0M |
| Dette à Court Terme | 0 | 0 | 0 | $618000 | $708000 | $1.2M | 0 | 0 | $3.0M | $3.1M |
| Passifs Courants | $9.5M | $11.0M | $4.6M | $4.7M | $7.9M | $10.9M | $6.7M | $23.0M | $15.2M | $16.4M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $6.8M |
| Passifs Totaux | $9.7M | $11.4M | $4.9M | $5.3M | $19.3M | $193.4M | $10.6M | $36.5M | $25.4M | $23.7M |
| Réserves | -$148.3M | -$198.5M | -$230.1M | -$299.5M | -$332.8M | -$95.6M | -$150.8M | -$187.2M | -$262.3M | -$352.6M |
| Capitaux Propres | $144.7M | $98.9M | $72.7M | $141.7M | $191.2M | -$91.9M | $98.6M | $186.0M | $310.4M | $264.9M |
| Dette Totale | $47000 | $32999 | $6000 | $1.2M | $12.1M | $6.4M | $4.7M | $16.3M | $12.4M | $9.9M |
| Dette Nette | -$103.0M | -$108.1M | -$76.9M | -$141.9M | -$180.4M | -$64.1M | -$77.3M | -$180.9M | -$300.0M | -$259.1M |
| Fonds de Roulement | $94.0M | $97.9M | $72.5M | $138.9M | $186.6M | $63.1M | $78.1M | $177.4M | $300.8M | $255.4M |
Santé financière
| Dette / Capitaux propres | 0.04 |
| Ratio de liquidité | 10.64 |
Rentabilité
| Rentabilité des capitaux propres | -45.11% |
| Rentabilité du capital investi | -53.72% |
| Rentabilité des actifs | -45.47% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ADCT · ALMS · AUTL · BNTC · FULC · LCTX · OCGN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de NGNE: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions